DrugBank Expands Coverage to Seven New Regions, Grows Global Influence
We are excited to announce that we have expanded our drug products and indications coverage with seven new regions: Austria, Colombia, Indonesia, Italy, Malaysia, Thailand, and Turkey. This allows DrugBank to better serve global customers and helps existing customers grow into new markets.
EDMONTON, CANADA—April 21, 2021—DrugBank, the world's most comprehensive and structured drug and molecular drug information resource, expands coverage to better serve global customers. The seven additional regions added to its product offering are Austria, Colombia, Indonesia, Italy, Malaysia, Thailand, and Turkey. On top of DrugBank’s existing coverage, customers can access new drug datasets for drug products and drug indications, specific to each new region.
“With these new additions, our pharmaceutical knowledge base becomes even more accessible and comprehensive,” explains Mike Wilson, CEO of DrugBank. “It allows new customers around the world better access to our product offerings, and helps existing customers grow into new markets”.
For clinical software customers, such as those in the electronic medical records (EMR) industry, they can use their local region as an entry point to the rest of DrugBank’s structured clinical information.
Those who operate in multiple regions can access clinical information through any combination of regions with one single API. More customers around the world can now search and store up-to-date medications faster and with more accuracy.
Moreover, the expanded coverage lets customers who provide advanced clinical decision support to use DrugBank’s detailed datasets for data analysis and insight generation. DrugBank solves a critical first step, for such users, as it normalizes multi-region medication data by mapping them to common identifiers, and keeps these mappings updated periodically.
“We are seeing more and more customers who not only need a drug lookup tool but perform complex data analysis to uncover insights and make predictions to improve health outcomes,” says Craig Knox, CTO of DrugBank. “Our structured datasets essentially help them skip an often time-consuming step, get more value out of their existing data, and get to insights faster.”
Along with the product coverage of Canada, the United States, and Europe, the newly added regions position DrugBank to cater to current needs and future demands of global customers.
For more information about DrugBank’s Clinical API, visit www.drugbank.com/clinical
About DrugBank
DrugBank augments human intelligence to improve the world’s health. We offer a suite of products that enable healthcare companies to improve healthcare delivery through precision medicine or clinical software application, while uncovering insights by applying data science to drug discovery. Our publicly accessible resource, DrugBank Online, has been cited in over 10,000 academic publications and is used by millions of researchers and health professionals globally.
To learn more about DrugBank, visit www.drugbank.com
Find us on social:
LinkedIn: linkedin.com/company/drugbank(@DrugBank)
Facebook: facebook.com/drugBankDatabase (@DrugBank)
Twitter: twitter.com/drugbankdb (@DrugBankDB)
Press Inquiries:
Kelvin Chen
Marketing Director, DrugBank
kelvin@drugbank.com